131 related articles for article (PubMed ID: 8188689)
21. Cell and type specificity of interferon action. Unusual characteristics of the transcriptional control of gene expression by interferon-gamma in T cells.
Gribaudo G; Gariglio M; Cavallo G; Landolfo S
Eur J Immunol; 1990 Jun; 20(6):1243-9. PubMed ID: 2114996
[TBL] [Abstract][Full Text] [Related]
22. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells.
Yamaoka T; Kojima S; Ichi S; Kashiwazaki Y; Koide T; Sokawa Y
J Interferon Cytokine Res; 1999 Dec; 19(12):1343-9. PubMed ID: 10638703
[TBL] [Abstract][Full Text] [Related]
23. The recombinant human interferon-gamma receptor is fully functional in a human x murine hybrid containing human chromosome 21.
Bono MR; Alcaïde-Loridan C; Letouzé B; Jouin H; Gobin SJ; Fellous M
Res Immunol; 1991; 142(9):765-72. PubMed ID: 1665572
[TBL] [Abstract][Full Text] [Related]
24. Functional role of type I and type II interferons in antiviral defense.
Müller U; Steinhoff U; Reis LF; Hemmi S; Pavlovic J; Zinkernagel RM; Aguet M
Science; 1994 Jun; 264(5167):1918-21. PubMed ID: 8009221
[TBL] [Abstract][Full Text] [Related]
25. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.
Ralph SJ; Wines BD; Payne MJ; Grubb D; Hatzinisiriou I; Linnane AW; Devenish RJ
J Immunol; 1995 Mar; 154(5):2248-56. PubMed ID: 7532663
[TBL] [Abstract][Full Text] [Related]
26. Basal and interferon-induced 2',5'-oligoadenylate synthetase activity in human placental trophoblast and trophoblast-derived malignant cell lines.
Dalsgaard AM; Aboagye-Mathiesen G; Justesen J; Zdravkovic M; Ebbesen P
Placenta; 1995 Mar; 16(2):137-46. PubMed ID: 7540757
[TBL] [Abstract][Full Text] [Related]
27. Human lung cancer nodules in organotypic culture: no evidence of correlation between the antiproliferative effects of interferons and the induction of 2',5'-oligoadenylate synthetase.
Martyré MC; Beaupain R; Falcoff E
Tumour Biol; 1988; 9(5):263-9. PubMed ID: 2461579
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.
Kochs G; Anzaghe M; Kronhart S; Wagner V; Gogesch P; Scheu S; Lienenklaus S; Waibler Z
J Virol; 2016 Oct; 90(20):9330-7. PubMed ID: 27512061
[TBL] [Abstract][Full Text] [Related]
29. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
Zaritsky LA; Bedsaul JR; Zoon KC
J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
[TBL] [Abstract][Full Text] [Related]
30. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
[TBL] [Abstract][Full Text] [Related]
31. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
32. Cross-resistance to human interferon-gamma of human interferon-beta-resistant F-IFr cells.
Morinaga N; Yonehara S; Kuwata T
J Gen Virol; 1984 Jun; 65 ( Pt 6)():1113-7. PubMed ID: 6327895
[TBL] [Abstract][Full Text] [Related]
33. The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation.
Kotenko SV; Izotova LS; Mirochnitchenko OV; Lee C; Pestka S
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5007-12. PubMed ID: 10220409
[TBL] [Abstract][Full Text] [Related]
34. Differential modulating effects of retinoic acid on interferon antiviral activity.
Ho CK; Ou BR; Wang CY; Chen HY; Kuwata T
Arch Virol; 1989; 109(1-2):25-34. PubMed ID: 2610595
[TBL] [Abstract][Full Text] [Related]
35. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
Billard C; Ferbus D; Sigaux F; Castaigne S; Degos L; Flandrin G; Falcoff E
Leuk Res; 1988; 12(1):11-8. PubMed ID: 2965776
[TBL] [Abstract][Full Text] [Related]
36. High and low potency interferon-alpha subtypes induce (2'-5') oligoadenylate synthetase with similar efficiency.
Goren T; Kapitkovsky A; Kimchi A; Rubinstein M
Virology; 1983 Oct; 130(2):273-80. PubMed ID: 6316631
[TBL] [Abstract][Full Text] [Related]
37. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
38. The interaction of interferon-alpha and -gamma: regulation of (2-5)A synthetase activity.
Fish EN; Hannigan GE; Banerjee K; Williams BR
Virology; 1988 Jul; 165(1):87-94. PubMed ID: 2455384
[TBL] [Abstract][Full Text] [Related]
39. Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.
Constantinescu SN; Croze E; Murti A; Wang C; Basu L; Hollander D; Russell-Harde D; Betts M; Garcia-Martinez V; Mullersman JE; Pfeffer LM
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10487-91. PubMed ID: 7479825
[TBL] [Abstract][Full Text] [Related]
40. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.
Wallach D; Fellous M; Revel M
Nature; 1982 Oct; 299(5886):833-6. PubMed ID: 6290893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
